These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 31940206)
1. Electrostatic Forces Control the Negative Allosteric Regulation in a Disordered Protein Switch. Wang Y; Brooks Iii CL J Phys Chem Lett; 2020 Feb; 11(3):864-868. PubMed ID: 31940206 [TBL] [Abstract][Full Text] [Related]
2. Hypersensitive termination of the hypoxic response by a disordered protein switch. Berlow RB; Dyson HJ; Wright PE Nature; 2017 Mar; 543(7645):447-451. PubMed ID: 28273070 [TBL] [Abstract][Full Text] [Related]
3. Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites. De Guzman RN; Martinez-Yamout MA; Dyson HJ; Wright PE J Biol Chem; 2004 Jan; 279(4):3042-9. PubMed ID: 14594809 [TBL] [Abstract][Full Text] [Related]
4. Competitive binding of HIF-1α and CITED2 to the TAZ1 domain of CBP from molecular simulations. Ruiz-Ortiz I; De Sancho D Phys Chem Chem Phys; 2020 Apr; 22(15):8118-8127. PubMed ID: 32242581 [TBL] [Abstract][Full Text] [Related]
5. Investigations of the underlying mechanisms of HIF-1α and CITED2 binding to TAZ1. Chu WT; Chu X; Wang J Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5595-5603. PubMed ID: 32123067 [TBL] [Abstract][Full Text] [Related]
6. Role of Backbone Dynamics in Modulating the Interactions of Disordered Ligands with the TAZ1 Domain of the CREB-Binding Protein. Berlow RB; Martinez-Yamout MA; Dyson HJ; Wright PE Biochemistry; 2019 Mar; 58(10):1354-1362. PubMed ID: 30775911 [TBL] [Abstract][Full Text] [Related]
7. Multivalency enables unidirectional switch-like competition between intrinsically disordered proteins. Berlow RB; Dyson HJ; Wright PE Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012986 [TBL] [Abstract][Full Text] [Related]
8. The molecular basis of allostery in a facilitated dissociation process. Appling FD; Berlow RB; Stanfield RL; Dyson HJ; Wright PE Structure; 2021 Dec; 29(12):1327-1338.e5. PubMed ID: 34520739 [TBL] [Abstract][Full Text] [Related]
9. An allosteric peptide inhibitor of HIF-1α regulates hypoxia-induced retinal neovascularization. Usui-Ouchi A; Aguilar E; Murinello S; Prins M; Gantner ML; Wright PE; Berlow RB; Friedlander M Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28297-28306. PubMed ID: 33106407 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114 [TBL] [Abstract][Full Text] [Related]
11. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α. Yoon H; Lim JH; Cho CH; Huang LE; Park JW Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214 [TBL] [Abstract][Full Text] [Related]
13. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850 [TBL] [Abstract][Full Text] [Related]
14. The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Yin Z; Haynie J; Yang X; Han B; Kiatchoosakun S; Restivo J; Yuan S; Prabhakar NR; Herrup K; Conlon RA; Hoit BD; Watanabe M; Yang YC Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10488-93. PubMed ID: 12149478 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response. Dames SA; Martinez-Yamout M; De Guzman RN; Dyson HJ; Wright PE Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5271-6. PubMed ID: 11959977 [TBL] [Abstract][Full Text] [Related]
16. Partial rescue of defects in Cited2-deficient embryos by HIF-1alpha heterozygosity. Xu B; Doughman Y; Turakhia M; Jiang W; Landsettle CE; Agani FH; Semenza GL; Watanabe M; Yang YC Dev Biol; 2007 Jan; 301(1):130-40. PubMed ID: 17022961 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the dynamics and the conformational entropy in the binding between TAZ1 and CTAD-HIF-1α. Nyqvist I; Dogan J Sci Rep; 2019 Nov; 9(1):16557. PubMed ID: 31719609 [TBL] [Abstract][Full Text] [Related]
18. CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition. Shin DH; Li SH; Chun YS; Huang LE; Kim MS; Park JW Oncogene; 2008 Mar; 27(13):1939-44. PubMed ID: 17906695 [TBL] [Abstract][Full Text] [Related]
19. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Bhattacharya S; Michels CL; Leung MK; Arany ZP; Kung AL; Livingston DM Genes Dev; 1999 Jan; 13(1):64-75. PubMed ID: 9887100 [TBL] [Abstract][Full Text] [Related]
20. Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes. Huang TQ; Wang Y; Ebrahem Q; Chen Y; Cheng C; Doughman YQ; Watanabe M; Dunwoodie SL; Yang YC Mol Vis; 2012; 18():1260-70. PubMed ID: 22665973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]